On Wednesday, Vincerx Pharma Inc (VINC) stock saw a decline, ending the day at $1.56 which represents a decrease of $-0.09 or -5.45% from the prior close of $1.65. The stock opened at $1.97 and ...
In a turbulent market environment, VINC stock has reached its 52-week low, trading at $1.62, with technical indicators from InvestingPro showing the stock in oversold territory. This price level ...
SAN MATEO, Calif. - Vincerx Pharma, Inc. (NASDAQ:VINC), a clinical-stage biopharmaceutical company with a current market capitalization of $2.77 million, and Oqory, Inc. announced promising results ...
Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx ...
In terms of valuation, Vincerx Pharma Inc’s market capitalization stands at $3.62 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Shares of Logility Supply Chain Solutions, Inc. LGTY rose sharply in today's pre-market trading after Aptean announced an ...
Knuckles: The Chris Nilan Story; One-man show with former Habs enforcer to hit the stage in late May
I have been a fan of Chris Nilan since he made his debut with the Montreal Canadiens during the 1979-80 season. Back then my ...
The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.
EST Vincerx Pharma (VINC) files $100M mixed securities shelfInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover ...
The proud Western New York municipality of Buffalo is in the midst of a unique interval of sporting success, built largely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback